Resultados de la búsqueda 111-120 of 7078 for Androgens

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...